- CNBC•2 days ago
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500.
- Motley Fool•3 days ago
After scrapping its lead candidate, Juno Therapeutics stock looks awfully cheap compared to Incyte. Find out if it's worth the risk.
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||130.75 x 100|
|Ask||131.10 x 400|
|Day's Range||127.56 - 131.89|
|52 Week Range||60.30 - 131.89|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||242.98|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|